{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:09Z","timestamp":1786119549773,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/aci.0b013e32833fea85","type":"journal-article","created":{"date-parts":[[2010,10,28]],"date-time":"2010-10-28T04:40:31Z","timestamp":1288240831000},"page":"551-556","source":"Crossref","is-referenced-by-count":49,"title":["Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency"],"prefix":"10.1097","volume":"10","author":[{"given":"Francesca","family":"Ferrua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Brigida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ni0610-457","article-title":"20 years of gene therapy for SCID","volume":"11","author":"Fischer","year":"2010","journal-title":"Nat Immunol"},{"key":"R2-7-20210128","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bmt.1705895","article-title":"Gene therapy for childhood immunological diseases","volume":"41","author":"Kohn","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R3-7-20210128","first-page":"689","article-title":"Ten years of gene therapy for primary immune deficiencies.","volume":"682-","author":"Aiuti","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R4-7-20210128","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2009-06-189209","article-title":"How I treat ADA deficiency","volume":"114","author":"Gaspar","year":"2009","journal-title":"Blood"},{"key":"R5-7-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of gene therapy for X-linked severe combined immunodeficiency","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N Engl J Med"},{"key":"R6-7-20210128","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1182\/blood-2007-05-092429","article-title":"Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients","volume":"111","author":"Cassani","year":"2008","journal-title":"Blood"},{"key":"R8-7-20210128","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/ACI.0b013e3283327da5","article-title":"New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy","volume":"9","author":"Sauer","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood-2009-03-209221","article-title":"ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL\/OPG imbalance and osteoblast insufficiency","volume":"114","author":"Sauer","year":"2009","journal-title":"Blood"},{"key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968\u20131999","volume":"361","author":"Antoine","year":"2003","journal-title":"Lancet"},{"key":"R11-7-20210128","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jpeds.2009.07.049","article-title":"Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or posttransplant GVHD prophylaxis.","volume":"155","author":"Railey","year":"2009","journal-title":"J Pediatr"},{"key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaci.2007.10.035","article-title":"Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency","volume":"121","author":"Slatter","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"R13-7-20210128","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood-2006-07-034678","article-title":"Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications","volume":"109","author":"Honig","year":"2007","journal-title":"Blood"},{"key":"R14-7-20210128","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood-2008-04-151332","article-title":"Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies","volume":"112","author":"Titman","year":"2008","journal-title":"Blood"},{"key":"R15-7-20210128","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaci.2007.08.007","article-title":"Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency","volume":"120","author":"Mazzolari","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1182\/blood-2008-09-177923","article-title":"Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency","volume":"113","author":"Neven","year":"2009","journal-title":"Blood"},{"key":"R17-7-20210128","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198703053161005","article-title":"Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase","volume":"316","author":"Hershfield","year":"1987","journal-title":"N Engl J Med"},{"key":"R18-7-20210128","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm0502-423","article-title":"Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement","volume":"8","author":"Aiuti","year":"2002","journal-title":"Nat Med"},{"key":"R19-7-20210128","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm0798-775","article-title":"T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates","volume":"4","author":"Kohn","year":"1998","journal-title":"Nat Med"},{"key":"R20-7-20210128","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"key":"R21-7-20210128","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.270.5235.470","article-title":"Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients","volume":"270","author":"Bordignon","year":"1995","journal-title":"Science"},{"key":"R22-7-20210128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"key":"R23-7-20210128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MOH.0b013e328302c807","article-title":"Recent advances in gene therapy for severe congenital immunodeficiency diseases","volume":"15","author":"Sokolic","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"R24-7-20210128","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"R25-7-20210128","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood-2006-06-031476","article-title":"Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report","volume":"109","author":"Engel","year":"2007","journal-title":"Blood"},{"issue":"S1","key":"R26-7-20210128","doi-asserted-by":"crossref","first-page":"S418","DOI":"10.1016\/j.ymthe.2006.08.1190","article-title":"Stem cell gene therapy with no pre-conditioning for the ADA-deficiency patients leads to generalized detoxification and delayed, but steady hematological reconstitution [abstract]","volume":"13","author":"Otsu","year":"2006","journal-title":"Mol Ther"},{"key":"R27-7-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.iac.2010.02.003","article-title":"Gene therapy for adenosine deaminase deficiency","volume":"30","author":"Cappelli","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"key":"R28-7-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ymthe.2006.06.007","article-title":"Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning","volume":"14","author":"Gaspar","year":"2006","journal-title":"Mol Ther"},{"key":"R29-7-20210128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.iac.2010.01.002","article-title":"Bone marrow transplantation and alternatives for adenosine deaminase deficiency","volume":"30","author":"Gaspar","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"key":"R30-7-20210128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2009.12.003","article-title":"Update on gene therapy for immunodeficiencies","volume":"135","author":"Kohn","year":"2010","journal-title":"Clin Immunol"},{"key":"R31-7-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2006.06244.x","article-title":"Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children","volume":"135","author":"Schwinger","year":"2006","journal-title":"Br J Haematol"},{"key":"R32-7-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1365-2141.2002.03560.x","article-title":"Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery","volume":"118","author":"Kalwak","year":"2002","journal-title":"Br J Haematol"},{"key":"R33-7-20210128","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood.V81.8.2021.2021","article-title":"Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation","volume":"81","author":"Dror","year":"1993","journal-title":"Blood"},{"key":"R34-7-20210128","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0022-3476(99)70291-X","article-title":"Influence of severe combined immunodeficiency phenotype on the outcome of HLA nonidentical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the European society for immunodeficiency","volume":"134","author":"Bertrand","year":"1999","journal-title":"J Pediatr"},{"key":"R35-7-20210128","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood.V99.3.872","article-title":"Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival","volume":"99","author":"Myers","year":"2002","journal-title":"Blood"},{"key":"R37-7-20210128","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1172\/JCI31666","article-title":"Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy","volume":"117","author":"Aiuti","year":"2007","journal-title":"J Clin Invest"},{"key":"R38-7-20210128","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1182\/blood-2009-02-202085","article-title":"Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy","volume":"114","author":"Cassani","year":"2009","journal-title":"Blood"},{"key":"R39-7-20210128","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"R40-7-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/blood-2009-03-211029","article-title":"Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome","volume":"114","author":"Poliani","year":"2009","journal-title":"Blood"},{"key":"R41-7-20210128","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"R42-7-20210128","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"R43-7-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.iac.2010.02.002","article-title":"Gene therapy for primary immunodeficiencies","volume":"30","author":"Fischer","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"key":"R44-7-20210128","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1181937","article-title":"Medicine. A comeback for gene therapy","volume":"326","author":"Naldini","year":"2009","journal-title":"Science"},{"key":"R45-7-20210128","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"R46-7-20210128","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2009.31","article-title":"Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models","volume":"17","author":"Marangoni","year":"2009","journal-title":"Mol Ther"},{"key":"R47-7-20210128","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2006-05-023507","article-title":"Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects","volume":"108","author":"Mortellaro","year":"2006","journal-title":"Blood"},{"key":"R48-7-20210128","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ymthe.2006.02.013","article-title":"In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency","volume":"13","author":"Carbonaro","year":"2006","journal-title":"Mol Ther"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ACI.0b013e32833fea85","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:32:41Z","timestamp":1786041161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130832-201012000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e32833fea85","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}